Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 40055 

consistent with the standard meeting 

process. 

CMS will make all meeting materials 

and related documents available at: 

https://www.cms.gov/Medicare/Coding/ 

ICD10/C-and-M-Meeting-Materials. Any 

inquiries related to the procedure code 

topics scheduled for the September 14, 

2021 ICD–10 Coordination and 

Maintenance Committee meeting that 

are under consideration for April 1, 

2022 or October 1, 2022 implementation 

should be sent to the CMS mailbox at: 

ICDProcedureCodeRequest@

cms.hhs.gov. 

ICD–10–CM Topics 

1. Apnea of Newborn and Related Issues 

2. Atrial Septal Defect 

3. Craniosynostosis 

4. Dementia 

5. Encounter for follow-up examination 

after completed treatment for 

malignant neoplasm 

6. Endometriosis 

7. Intracranial Injury with Unknown 

LOC 

8. Long-term (current) drug therapy 

9. Primary Blast Injury 

10. Problems Related to Upbringing 

11. Short Stature Due to Endocrine 

Disorder 

12. Addenda 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–15801 Filed 7–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–1046; Docket No. CDC–2021– 

0074] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled National Breast and Cervical 

Cancer Early Detection Program 

(NBCCEDP) Monitoring Activities. 

Proposed study is designed to collect 

information about implementation, 

including delivery of screening and 

follow-up clinical services, and 

outcomes of the NBCCEDP. 

DATES: CDC must receive written 

comments on or before September 24, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0074 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP) 

Monitoring Activities—(OMB Control 

No. 0920–1046, Exp. 11/30/2021)— 

Revision—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

CDC is requesting a Revision of the 

information collection with the OMB 

Control Number 0920–1046, titled 

‘‘National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP) 

Monitoring Activities.’’ In the previous 

OMB approval period, information 

collection consisted of an annual 

NBCCEDP survey and clinic-level data 

collection. In the next OMB approval 

period, information collection will 

consist of a revised NBCCEDP survey, 

revised clinic-level data collection, new 

quarterly program update, new service 

delivery projection worksheet, and the 

addition of previously approved 

minimum data elements (MDEs; OMB 

Control No. 0920–0571, Exp. 11/30/ 

2021) to increase efficiency. The 

number of respondents will remain the 

same and the total estimated annualized 

burden will increase from 683 to 1,216. 

Breast and cervical cancers are 

prevalent among U.S. women. In 2017, 

the U.S. experienced 250,520 new cases 

and 42,000 deaths as a result of breast 


jbell on DSKJLSW7X2PROD with NOTICES
40056 Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 

cancer, as well as 12,831 new cases and 

4,207 deaths as a result of cervical 

cancer. Evidence shows that deaths 

from both breast and cervical cancers 

can be avoided by increasing screening 

services—mammography and PAP 

tests—among women. However, 

screening is typically underutilized 

among women who are under- or 

uninsured, have no regular source of 

healthcare, or who recently immigrated 

to the U.S. As a longstanding priority 

within chronic disease prevention, CDC 

focuses on increasing access to these 

cancer screenings, particularly among 

women who may be at increased risk. 

To improve access to cancer 

screening, Congress passed the Breast 

and Cervical Cancer Mortality 

Prevention Act of 1990 (Pub. L. 106– 

354), which directed CDC to create the 

National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP). 

The NBCCEDP currently provides 

funding to 70 awardees under ‘‘Cancer 

Prevention and Control Programs for 

State, Territorial, and Tribal 

Organizations (DP17–1701).’’ NBCCEDP 

awardees include states or their bona 

fide agents; U.S. territories; and tribes or 

tribal organizations. The purpose of 

NBCCEDP is to increase breast and 

cervical cancer screening rates among 

women residing within defined 

geographical locations (as determined 

by the funded program) who are at or 

below 250% of the federal poverty level; 

aged 40–64 years for breast cancer 

services, and aged 21–64 years for 

cervical cancer services; and under- or 

uninsured. 

In 2022, CDC will issue a new Notice 

of Funding Opportunity (DP22–2202) to 

continue this mission. Consistent with 

programmatic changes, the information 

collection plan has also been redesigned 

to update existing, and add new data 

collection instruments, and to integrate 

the previously approved MDEs into this 

single approval package to increase 

efficiency of information collection for 

the NBCCEDP. This revised information 

collection will allow CDC to provide 

routine monitoring feedback to 

awardees based on their data 

submissions, tailor technical assistance 

(TA) as needed, support program 

planning, and assess program outcomes. 

CDC proposes five forms of 

information collection. First, the 

NBCCEDP survey will be submitted to 

CDC annually and collects information 

to monitor awardees’ TA needs, external 

funding sources, partnerships, EBI 

implementation, and COVID–19 impact. 

Minor revisions to survey questions and 

formatting reflect the program under 

DP22–2202. Second, clinic-level data 

will be submitted to CDC at baseline 

and annually for all partnering health 

system clinic sites—an estimated six 

clinics per awardee for breast cancer 

data and six clinics per awardee for 

cervical cancer data. Clinic-level data 

allow CDC to assess health system, 

clinic, and patient population 

characteristics; monitoring and quality 

improvement activities; EBI 

implementation; and baseline or annual 

screening rates. Minor revisions were 

made to variable wording, formatting 

(e.g., split or combined variables), and 

response options to improve data 

quality. Third, quarterly program 

updates will be submitted to CDC four 

times per year to monitor award 

spending, service delivery, staff 

vacancies, program challenges and 

successes, and TA needs. This is a new 

information collection. Fourth, the 

service delivery projection worksheet 

will be submitted to CDC annually to 

provide an estimate of the number of 

women served for breast and cervical 

cancer. Fifth, the minimum data 

elements (MDEs) will be submitted to 

CDC twice per year to monitor patient 

demographics; breast and cervical 

cancer screening, diagnosis, and 

treatment; timeliness of services; and 

patient navigation. This information 

collection was previously approved 

(OMB No. 0920–0571, exp. 03/30/2022) 

and incorporated into this approval 

package for increased efficiency for 

NBCCEDP information collection 

efforts. 

The proposed information collections 

will allow CDC to gauge progress in 

meeting NBCCEDP program goals and 

monitor implementation activities, 

evaluate outcomes, and identify 

awardee TA needs. In addition, findings 

will inform program improvement and 

help identify successful activities that 

need to be maintained, replicated, or 

expanded. 

OMB approval is requested for three 

years. CDC requests approval for an 

estimated 1,216 annual burden hours. 

Participation is required for NBCCEDP 

awardees. There are no costs to 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

NBCCEDP Awardees ............ Annual NBCCEDP Survey ........................... 70 1 45/60 53 

NBCCEDP Clinic-level Information Collection Instrument—Breast.70 6 45/60 315 

NBCCEDP Clinic-level Information Collection Instrument—Cervical.70 6 45/60 315 

Quarterly Program Update ........................... 70 4 32/60 149 

Service Delivery Projection Worksheet ........ 70 1 29/60 34 

MDEs ............................................................ 70 2 150/60 350 

Total ............................... ....................................................................... ........................ ........................ ........................ 1,216 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices 40057 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–15796 Filed 7–23–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–0017; Docket No. CDC–2021– 

0073] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Application for Training, which 

supports the management and 

evaluation of online training and 

professional development opportunities 

for public health and health care 

professionals. 

DATES: CDC must receive written 

comments on or before September 24, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0073 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Application for Training (OMB 

Control No. 0920–0017, Exp. 04/30/ 

2022)—Revision—Center for 

Surveillance, Epidemiology, and 

Laboratory Services (CSELS), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

This Information Collection Request 

(ICR) is for the Revision of a currently 

approved ICR (OMB Control No. 0920– 

0017, Expiration 4/30/2022. Approval is 

requested for three years. The mission of 

CDC’s Division of Scientific Education 

and Professional Development (DSEPD) 

is to support the development of a 

competent, sustainable, and empowered 

public health workforce. Professionals 

in public health, epidemiology, 

medicine, economics, information 

science, veterinary medicine, nursing, 

public policy, and other related 

professions seek professional 

development opportunities (both 

accredited and nonaccredited) through 

two CDC learning management systems. 

These two learning management 

systems are Training and Continuing 

Education Online (TCEO) (for 

accredited courses) and CDC TRAIN (for 

nonaccredited courses developed by 

CDC programs, grantees, and other 

funded partners). Access to quality and 

accredited learning programs and 

products through these two systems 

allow for the public health workforce to 

broaden their knowledge and skills to 

improve the science and practice of 

public health for domestic and 

international impact. 

The overarching purpose of the ICR is 

to continually improve CDC training 

activities, and maintain CDC 

compliance with mandatory 

accreditation organization standards by 

efficiently collecting information 

through CDC’s Training and Continuing 

Education Online (TCEO) and CDC 

TRAIN systems, while navigating a 

future merger that moves to using a 

single system (CDC TRAIN). 

This Revision requests to extend 

current approval of the TCEO forms, 

with one minor change, namely to add 

two new response options for one 

question on the TCEO New Participant 

Registration. This Revision also requests 

to add CDC TRAIN as a data collection 

system and add two CDC TRAIN 

standard training evaluation tools (one 

for use immediately after the course is 

taken, and one 3–6 months after the 

course is taken) that will be employed 

on the learning management system. 

This proposed change will provide CDC 

with an efficient, effective, and secure 

electronic mechanism for collecting, 

processing, and monitoring trainingrelated information. 

CDC will use information collected in 

both systems to evaluate and improve 

courses based on learner feedback. At 

this time, TCEO is also used to generate 

certificates of attendance and verify 

training completion, review and 

approve proposals for educational 

activities to receive continuing 

education accreditation, and ensure 

compliance with mandatory 

accreditation standards. 

All data will be collected online, 

using secure electronic web-based 


jbell on DSKJLSW7X2PROD with NOTICES